Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Afatinib × Clear all

Phase

Status

Completed 36 Unknown 11 Terminated 8 Withdrawn 4 Active not recruiting 3 Recruiting 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Biopsy 6 pembrolizumab 4 Capecitabine 4 Radiosurgery 3 Nivolumab 3 Fluorouracil 3 Docetaxel 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 spartalizumab 2 lenvatinib 2 balstilimab 2 atezolizumab 2 Radiation 2 Paclitaxel 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2 Lenalidomide 2 Irinotecan 2 Gemcitabine 2 Epirubicin 2 Drug Therapy 2 Cyclophosphamide 2 Cisplatin 2 zanubrutinib 1 venetoclax 1 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02470065 2016-01-22

REMNANT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡